HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Paula Loria Selected Research

(3S,3aR)- 2- (3- chloro- 4- cyanophenyl)- 3- cyclopentyl- 3,3a,4,5- tetrahydro- 2H- benzo(g)indazole- 7- carboxylic acid

1/2013PF-03882845, a non-steroidal mineralocorticoid receptor antagonist, prevents renal injury with reduced risk of hyperkalemia in an animal model of nephropathy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Paula Loria Research Topics

Disease

2Hyperkalemia
01/2013 - 10/2011
1Fibrosis (Cirrhosis)
01/2013
1Diabetic Nephropathies (Diabetic Nephropathy)
10/2011

Drug/Important Bio-Agent (IBA)

1(3S,3aR)- 2- (3- chloro- 4- cyanophenyl)- 3- cyclopentyl- 3,3a,4,5- tetrahydro- 2H- benzo(g)indazole- 7- carboxylic acidIBA
01/2013
1Eplerenone (Inspra)FDA LinkGeneric
01/2013
1AldosteroneIBA
01/2013
1Mineralocorticoid Receptor AntagonistsIBA
01/2013
1CollagenIBA
01/2013
1salicylhydroxamic acid (SHAM)IBA
01/2013
1Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA
10/2011
1Mineralocorticoid Receptors (Mineralocorticoid Receptor)IBA
10/2011